AACR 2018 - Thomas Schlange about the CANCER-ID initiative

The lack of common standards creates a major obstacle for the broader use of liquid biopsies in clinical settings. Dr. Thomas Schlange explains how the CANCER-ID Initiative is paving ground for making assays based on non-invasive methods more accessible to cancer patients.

For more visit: http://aacr2018.qiagen.com